Protéines de fusion virale : Questions médicales fréquentes
Nom anglais: Viral Fusion Proteins
Descriptor UI:D014760
Tree Number:D12.776.964.970.880.910
Termes MeSH sélectionnés :
Preliminary Data
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Protéines de fusion virale : Questions médicales les plus fréquentes",
"headline": "Protéines de fusion virale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Protéines de fusion virale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-13",
"dateModified": "2025-05-08",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Protéines de fusion virale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines de l'enveloppe virale",
"url": "https://questionsmedicales.fr/mesh/D014759",
"about": {
"@type": "MedicalCondition",
"name": "Protéines de l'enveloppe virale",
"code": {
"@type": "MedicalCode",
"code": "D014759",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.964.970.880"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Glycoprotéine de spicule des coronavirus",
"alternateName": "Spike Glycoprotein, Coronavirus",
"url": "https://questionsmedicales.fr/mesh/D064370",
"about": {
"@type": "MedicalCondition",
"name": "Glycoprotéine de spicule des coronavirus",
"code": {
"@type": "MedicalCode",
"code": "D064370",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.964.970.880.910.665"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Protéines de fusion virale",
"alternateName": "Viral Fusion Proteins",
"code": {
"@type": "MedicalCode",
"code": "D014760",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Jiachen Huang",
"url": "https://questionsmedicales.fr/author/Jiachen%20Huang",
"affiliation": {
"@type": "Organization",
"name": "Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia; Athens, GA 30602, USA."
}
},
{
"@type": "Person",
"name": "Jarrod J Mousa",
"url": "https://questionsmedicales.fr/author/Jarrod%20J%20Mousa",
"affiliation": {
"@type": "Organization",
"name": "Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia; Athens, GA 30602, USA."
}
},
{
"@type": "Person",
"name": "Wen Chang",
"url": "https://questionsmedicales.fr/author/Wen%20Chang",
"affiliation": {
"@type": "Organization",
"name": "Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan."
}
},
{
"@type": "Person",
"name": "Rebecca Ellis Dutch",
"url": "https://questionsmedicales.fr/author/Rebecca%20Ellis%20Dutch",
"affiliation": {
"@type": "Organization",
"name": "Department of Molecular and Cellular Biochemistry, University of Kentucky, 741 South Limestone Street, Lexington, KY 40536, USA."
}
},
{
"@type": "Person",
"name": "Markus Hoffmann",
"url": "https://questionsmedicales.fr/author/Markus%20Hoffmann",
"affiliation": {
"@type": "Organization",
"name": "Infection Biology Unit, German Primate Center, Leibniz Institute for Primate Research, Göttingen, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Gamma glutamyl transferases in association with cardiovascular risk scores in non-diabetic hypertensive Cameroonians: preliminary data from HYRICCA study.",
"datePublished": "2022-09-15",
"url": "https://questionsmedicales.fr/article/36109817",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13104-022-06190-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cardiovascular Disease Risk in a Cohort of Virologically Suppressed People Living with HIV Switching to Doravirine: Preliminary Data from the Real Life.",
"datePublished": "2022-10-19",
"url": "https://questionsmedicales.fr/article/36166220",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1089/AID.2022.0050"
}
},
{
"@type": "ScholarlyArticle",
"name": "Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter study.",
"datePublished": "2023-10-11",
"url": "https://questionsmedicales.fr/article/37821952",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13075-023-03182-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "COVID-19 pandemic increases the occurrence of nursing burnout syndrome: an interrupted time-series analysis of preliminary data from 38 countries.",
"datePublished": "2023-04-11",
"url": "https://questionsmedicales.fr/article/37060733",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.nepr.2023.103643"
}
},
{
"@type": "ScholarlyArticle",
"name": "Safety use of high frequency oscillatory ventilation in transport of newborn infants affected by severe respiratory failure: preliminary data in central Tuscany.",
"datePublished": "2022-06-10",
"url": "https://questionsmedicales.fr/article/35689179",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12887-022-03393-0"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines virales",
"item": "https://questionsmedicales.fr/mesh/D014764"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protéines virales structurales",
"item": "https://questionsmedicales.fr/mesh/D015678"
},
{
"@type": "ListItem",
"position": 6,
"name": "Protéines de l'enveloppe virale",
"item": "https://questionsmedicales.fr/mesh/D014759"
},
{
"@type": "ListItem",
"position": 7,
"name": "Protéines de fusion virale",
"item": "https://questionsmedicales.fr/mesh/D014760"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Protéines de fusion virale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Protéines de fusion virale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Protéines de fusion virale",
"description": "Comment diagnostiquer une infection virale liée aux protéines de fusion ?\nQuels tests sont utilisés pour détecter les protéines de fusion ?\nLes biopsies sont-elles utiles pour le diagnostic ?\nQuels symptômes peuvent indiquer une infection virale ?\nLes tests d'imagerie sont-ils nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D014760?mesh_terms=Preliminary+Data&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Protéines de fusion virale",
"description": "Quels sont les symptômes courants d'une infection virale ?\nLes symptômes varient-ils selon le virus ?\nLes symptômes peuvent-ils être graves ?\nComment les symptômes évoluent-ils avec le temps ?\nLes symptômes sont-ils similaires à ceux d'autres maladies ?",
"url": "https://questionsmedicales.fr/mesh/D014760?mesh_terms=Preliminary+Data&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Protéines de fusion virale",
"description": "Comment prévenir les infections virales ?\nLes masques aident-ils à prévenir la transmission virale ?\nLes voyages augmentent-ils le risque d'infection virale ?\nL'alimentation influence-t-elle la prévention des infections ?\nLes mesures de distanciation sociale sont-elles efficaces ?",
"url": "https://questionsmedicales.fr/mesh/D014760?mesh_terms=Preliminary+Data&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Protéines de fusion virale",
"description": "Quels traitements sont disponibles pour les infections virales ?\nLes antibiotiques sont-ils efficaces contre les infections virales ?\nLa vaccination peut-elle prévenir les infections virales ?\nLes traitements varient-ils selon le type de virus ?\nLes traitements sont-ils efficaces contre toutes les souches virales ?",
"url": "https://questionsmedicales.fr/mesh/D014760?mesh_terms=Preliminary+Data&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Protéines de fusion virale",
"description": "Quelles sont les complications possibles des infections virales ?\nLes complications varient-elles selon le virus ?\nComment prévenir les complications des infections virales ?\nLes complications peuvent-elles être mortelles ?\nLes personnes âgées sont-elles plus à risque de complications ?",
"url": "https://questionsmedicales.fr/mesh/D014760?mesh_terms=Preliminary+Data&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Protéines de fusion virale",
"description": "Quels sont les principaux facteurs de risque d'infection virale ?\nLe mode de vie influence-t-il le risque d'infection ?\nLes voyages à l'étranger augmentent-ils le risque ?\nLes contacts avec des animaux peuvent-ils être un facteur de risque ?\nLes conditions de vie en collectivité augmentent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D014760?mesh_terms=Preliminary+Data&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection virale liée aux protéines de fusion ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sérologiques et des cultures virales."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter les protéines de fusion ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests ELISA et des techniques de PCR peuvent être utilisés pour détecter ces protéines."
}
},
{
"@type": "Question",
"name": "Les biopsies sont-elles utiles pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les biopsies peuvent aider à identifier des infections virales spécifiques."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une infection virale ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, fatigue, éruptions cutanées et douleurs musculaires peuvent être des indicateurs."
}
},
{
"@type": "Question",
"name": "Les tests d'imagerie sont-ils nécessaires ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Généralement non, mais ils peuvent être utilisés pour évaluer des complications."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants d'une infection virale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, toux, fatigue, douleurs musculaires et éruptions cutanées sont fréquents."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le virus ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque virus peut provoquer des symptômes spécifiques selon son type."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils être graves ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections virales peuvent entraîner des complications graves."
}
},
{
"@type": "Question",
"name": "Comment les symptômes évoluent-ils avec le temps ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent s'aggraver ou s'améliorer selon la réponse immunitaire de l'hôte."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils similaires à ceux d'autres maladies ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être confondus avec ceux de maladies bactériennes ou auto-immunes."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections virales ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination, l'hygiène des mains et l'évitement des contacts sont essentiels."
}
},
{
"@type": "Question",
"name": "Les masques aident-ils à prévenir la transmission virale ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les masques peuvent réduire la transmission des virus respiratoires."
}
},
{
"@type": "Question",
"name": "Les voyages augmentent-ils le risque d'infection virale ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyages peuvent exposer à de nouveaux virus et augmenter le risque d'infection."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle la prévention des infections ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée renforce le système immunitaire et aide à prévenir les infections."
}
},
{
"@type": "Question",
"name": "Les mesures de distanciation sociale sont-elles efficaces ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles réduisent la propagation des infections virales dans la communauté."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les infections virales ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antiviraux, les soins de soutien et les traitements symptomatiques sont courants."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils efficaces contre les infections virales ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne sont pas efficaces contre les virus, seulement contre les bactéries."
}
},
{
"@type": "Question",
"name": "La vaccination peut-elle prévenir les infections virales ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines vaccinations peuvent prévenir des infections virales spécifiques."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon le type de virus ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque virus peut nécessiter un traitement spécifique adapté à son mécanisme."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils efficaces contre toutes les souches virales ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, certaines souches peuvent être résistantes aux traitements disponibles."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles des infections virales ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pneumonie, encéphalite et défaillance organique sont des complications graves."
}
},
{
"@type": "Question",
"name": "Les complications varient-elles selon le virus ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque virus peut entraîner des complications spécifiques selon son tropisme."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications des infections virales ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un traitement précoce et une surveillance médicale peuvent aider à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être mortelles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines complications peuvent entraîner la mort si elles ne sont pas traitées rapidement."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque de complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées ont un risque accru de complications graves liées aux infections virales."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'infection virale ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'immunodépression, le vieillissement et les conditions de santé préexistantes augmentent le risque."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque d'infection ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain peut réduire le risque d'infections virales."
}
},
{
"@type": "Question",
"name": "Les voyages à l'étranger augmentent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones à forte prévalence virale augmente le risque d'infection."
}
},
{
"@type": "Question",
"name": "Les contacts avec des animaux peuvent-ils être un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains virus zoonotiques peuvent être transmis par contact avec des animaux infectés."
}
},
{
"@type": "Question",
"name": "Les conditions de vie en collectivité augmentent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les environnements surpeuplés favorisent la transmission des infections virales."
}
}
]
}
]
}
The usefulness of gamma glutamyl transferase (GGT) as biomarker of cardiovascular risk (CVR) remains unexplored in sub-Saharan Africans. To evaluate their relevance on CVR assessment in non-diabetic h...
We found a positive but weak association between GGT and PAI on linear regression [0.004 (0.001; 0.007); p = 0.021], which was dependent of triglycerides levels (r = 0.17; p = 0.03). We did not find a...
Aim of this study is to assess the impact of doravirine (DOR)-based regimens on cardiovascular risk in treatment-experienced people living with HIV (PLWHIV). We retrospectively analyzed a cohort of 40...
Upadacitinib (UPA) is a selective JAK inhibitor recently approved for the treatment of psoriatic arthritis (PsA). In this post-approval study, we aimed to evaluate the effectiveness and safety of UPA ...
One hundred and twenty-six patients with PsA treated with UPA were enrolled in 10 Italian centres. UPA effectiveness outcomes, such as the proportion of patients with MDA status, DAPSA remission, and ...
At baseline, 124/126 (98%) and 54/126 (43%) patients showed peripheral and axial involvement, respectively; 110 (87%) patients were intolerant or resistant to biologic DMARDs. At 24 weeks, MDA status,...
This is one of the first real-life studies supporting the effectiveness of UPA and its safety profile in PsA patients. Furthermore, the study identifies predictors of MDA response to UPA treatment at ...
To evaluate the trends in nursing burnout rates before and during the coronavirus 2019 restrictions....
Meta-analysis was used to extract the data on global nursing burnout from 1 Jan. 2010-15 Dec. 2022. An interrupted time-series analysis using segmented ordinary least squares (OLS) regression models w...
Before the epidemic (April 2020), the nursing burnout rate rose with 0.0007497 (95% CI: 0.0000316, 0.0014677, t = 2.07, P = 0.041) per month. The trend of nursing burnout rate has increased by 0.02310...
The study indicated that the Covid-19 restrictions had an impact on nursing burnout, increasing the occurrence of nursing burnout syndrome....
Neonatal Emergency Transport Services play a fundamental role in neonatal care. Stabilization before transport of newborns suffering from severe respiratory failure is often a challenging problem and ...
A retrospective analysis was performed reviewing medical records of the neonates transported by Meyer Children Hospital's Neonatal Transport Service between May 2018 and December 2020, and newborns tr...
Out of the approximate 400 newborns transported during the analysis period, 9 were transported in HFOV. We did not find any statistically significant difference in vital parameters, hemogas-analytical...
The interest of our report is in the possibility of using HFOV during inter-hospital neonatal transfer. As far as our experience has shown, HFOV appears to be safe for the transportation of newborns w...
To evaluate the efficacy and safety of SARS-CoV-2 vaccine in patients with rheumatic and immune-mediated inflammatory diseases (IMIDs) in Argentina: the SAR-CoVAC registry....
SAR-CoVAC is a national, multicenter, and observational registry. Adult patients with rheumatic or IMIDs vaccinated for SARS-CoV-2 were consecutively included between June 1 and September 17, 2021. So...
A total of 1234 patients were included, 79% were female, with a mean age of 57.8 (SD 14.1) years. The most frequent diseases were rheumatoid arthritis (41.2%), osteoarthritis (14.5%), psoriasis (12.7%...
In this national cohort of patients, the most common vaccines used were Gam-COVID-Vac and ChAdOx1 nCoV-19. A quarter of the patients presented an AE and 5.1% presented SARS-CoV-2 infection after vacci...
This study has been registered in ClinicalTrials.gov under the number: NCT04845997. Key Points • This study shows real-world data about efficacy and safety of SARS-CoV-2 vaccination in patients with r...
The management of prediabetes and hyperglycemia is an increasingly important aspect of care in patients with thalassemia. In light of the limited evidence about the management of GD (glucose dysregula...
A questionnaire was prepared and distributed to the tertiary thalassemia care Centers of ICET-A Network....
Eight thalassemia care Centers [Bulgaria, Greece, Iran, Italy (4 Centers) and Qatar], following 1.554 with transfusion-dependent thalassemia (TDT), 132 (8.4%) with diabetes and 687 with non-transfusio...
This retrospective study covers an unexplored area of research in patients with thalassemia and GD. Oral GLAs appear to be safe and effective for the treatment of diabetes mellitus in patients with th...
The objective of this study is to evaluate compliance with and effectiveness of notched sound therapy (NST) administered through a mobile application in improving symptoms of patients experiencing chr...
A prospective randomized control trial was done....
The study was done at a tertiary referral center....
Adult patients with tinnitus were monitored....
Patients were randomized at enrollment to either the NST or a standard of care (SOC) group. NST arm included, in addition to SOC, a free subscription to NST mobile application, whereas the SOC arm inc...
The main outcome measures were continued enrollment in study, compliance with the therapy, frequency and duration of therapy use, and change from the baseline in the Tinnitus Handicap Inventory (THI)....
Patients in the NST group were 2.25 times more likely to use the NST application for 3 months postenrollment. Only 33% of users in the NST group listened for the prescribed 2 h/d compared with 0% of u...
Monitoring tinnitus for 3 months leads to a decrease in subjective symptoms regardless of NST use. Patients who received a free subscription to the application were more likely to continue with therap...
As previously reported, an increased repolarization temporal imbalance induces a higher risk of total/cardiovascular mortality....
The aim of this study was to assess if the electrocardiographic short period markers of repolarization temporal dispersion could be predictive of the hospital stay length and mortality in patients wit...
Mean, standard deviation (SD), and normalized variance (VN) of QT (QT) and Tpeak-Tend (Te) were obtained on 5-min ECG recording in 139 patients hospitalized for acutely decompensated CHF, subgrouping ...
We observed an increase of short-period repolarization variables (TeSD and TeVN, p < .05), a decrease of blood pressure (p < .05), lower ejection fraction (p < .05), and higher plasma level of biomark...
A longer hospital stay is considered a clinical surrogate of CHF severity, we confirmed this finding. Therefore, these electrical and simple parameters could be used as noninvasive, transmissible, ine...
An increasing number of countries have been introducing acellular pertussis vaccination during pregnancy for the prevention of neonatal pertussis. In response to the fact that infantile pertussis case...